F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
News
Dolly Parton Was a Trailblazer in Business, Too
Her vision to launch businesses to bring fans closer while protecting her intellectual property was ahead of her time.
Meta to Pay Up to $17.1 Billion in Landmark Settlement Over Social Media Addiction Claims
The social media giant settled with 47 states, the District of Columbia and U.S. territories, and agreed to make major...
Wall St. Scrutinizes Nvidia’s Deal Machine
Investors are awaiting the chipmaker’s latest quarterly earnings — and are anxious about its huge portfolio of artificial intelligence investments.
Inflation Remains Elevated as Energy Costs Push on Prices
The Personal Consumption Expenditure index, the Federal Reserve’s preferred inflation tracker, held steady in July.
Soaring Diesel Prices Are Helping Oil Companies and Hurting Consumers
The cost of the fuel, used in farm machinery, trucks and other heavy equipment, has surged because of the war...
Harry Styles and the Residencies Taking Over the Music Industry
Harry Styles’s latest Madison Square Garden takeover is part of a trend that some say transfers the cost of touring...
Under Threat, Saudi Arabia Reroutes Oil Exports Yet Again
Forced away from the Strait of Hormuz in the Persian Gulf, the Saudis turned to the Red Sea. Now they...
Soaring Diesel Prices Are Helping Oil Companies and Hurting Consumers
The cost of the fuel, used in farm machinery, trucks and other heavy equipment, has surged because of the war...
Bessent Faces Credibility Test in Quest to Tame Markets
The Treasury secretary is confronting the limits of his ability to reshape the economy ahead of midterm elections.